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Abstract
Aims/hypothesis Gestational diabetes mellitus (GDM) is reported to be associated with childhood obesity, however the magni-
tude of this association and relation to intrauterine growth is uncertain. We, therefore, aimed to assess whether the growth
trajectories of large for gestational age (LGA) and non-LGA offspring of mothers with GDM (OGDM) are different until early
adolescence. We also aimed to explore whether growth trajectories of OGDM differ from those of offspring of mothers with type
1 or 2 diabetes (ODM1, ODM2).
Methods We studied height and BMI standard deviation score (SDS) of the OGDM group, up to the age of 14 years, with
subgroup analysis comparing LGAwith non-LGA at birth as a reflection of the intrauterine environment. All mothers with GDM
who delivered at the University Medical Center Utrecht between 1990 and 2006 were contacted to participate; informed consent
was received for 104 OGDM of 93mothers. Offspring data were collected through Dutch infant welfare centres. Recorded height
and weight were converted to BMI and age- and sex-specific SDS values for Dutch children. Additionally, we compared the
OGDM group with ODM1 and ODM2 groups in order to identify those offspring with the highest risk of becoming overweight.
Growth trajectories were compared between non-LGA and LGA OGDM and between OGDM, ODM1 and ODM2, using a
random-effects model. In the longitudinal follow-up a mean of 7.4 ± 2 measurements per infant were available.
Results Mothers had a prepregnancy BMI of 25.8 kg/m2 and 24% of their infants were LGA at birth. Heights of OGDMwere no
different from those of the Dutch Growth Study. Non-LGA OGDM showed a BMI SDS comparable with that of the reference
population, with a slight increase in early adolescence. LGA OGDM had a higher BMI SDS trajectory than non-LGA OGDM
and the reference population, which plateaued at around 10 years of age. Comparison of growth trajectories of OGDM, ODM1
and ODM2 showedODM2 to have the highest trajectory followed byODM1 and OGDM,with the LGA counterparts of all three
offspring groups in the highest BMI SDS ranges.
Conclusions/interpretation Until early adolescence, OGDM have a BMI that is 0.5 SDS higher than that of the Dutch back-
ground population. LGAOGDM appear to be at particularly higher risk of being overweight in adolescence compared with non-
LGA OGDM, putting them also at a higher lifetime risk of being overweight and developing obesity. ODM2 showed the highest
BMI SDS values and had an average BMI SDS of +1.6 until the age of 14, when it became +2 SD. These results emphasize the
importance of adequate recognition and timely treatment of maternal gestational diabetes to prevent fetal macrosomia in
obstetrics.
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LGA Large for gestational age
ODM1 Offspring of mothers with type 1 diabetes
ODM2 Offspring of mothers with type 2 diabetes
OGDM Offspring of mothers with gestational diabetes
SDS Standard deviation score
Introduction
Gestational diabetes (GDM) is defined as any degree of glu-
cose intolerance that is diagnosed in the second or third tri-
mester of pregnancy and that is not clearly overt diabetes [1].
The prevalence of GDM is rising worldwide [2, 3] and the
condition is associated with adverse pregnancy outcomes such
as an increased risk of large-for-gestational-age (LGA) neo-
nates and birth complications [4]. These LGA infants have an
increased fat mass and decreased lean body mass compared
with LGA infants from non-diabetic women [5]; their intra-
uterine growth is disproportionate, with an increased abdom-
inal circumference compared with the head circumference ra-
tio [6]. In adolescence, offspring of mothers with GDM
(OGDM) have been shown to have an increased risk of ab-
normal glucose metabolism and hypertension [7, 8]. It is not
known whether intrauterine adiposity adds to postnatal adi-
posity and subsequent health issues.
To anticipate childhood obesity and formulate preventive
strategies, it is important to perform longitudinal studies of
BMI. Studies of BMI in OGDM have mostly been cross-
sectional in design [7–16] and only a few longitudinal studies
have been performed in GDM [17–20]. The cross-sectional
cohorts showed an increased risk for developing adiposity
compared with children not exposed in utero to diabetes [7,
10, 12]; even mild GDM, untreated or treated only with die-
tary intervention, was associated with an increase in offspring
obesity between the ages of 5 and 10 years [11]. Pooling the
different cross-sectional studies is difficult due to different
definitions of endpoints used (obesity, BMI or BMI z score)
[7, 8, 10, 13]. Also, the definitions used for obesity differed
[10, 13]. The available longitudinal data are unsuitable for
comparison due to differences in methodology: different age
categories and follow-up periods (age 6 months to 13 years)
and different statistical methods and different assessments of
body mass (BMI, BMI standard deviation score [SDS], quin-
tiles and skinfold thickness) [17–21]. Additionally, different
types of maternal diabetes were included in most studies [14,
15, 21, 22]. The available evidence on longitudinal BMI data
in OGDM show a higher childhood BMI up to the age of
13 years compared with offspring of non-diabetic pregnancies
[21], and a higher childhood BMI SDS up to age 8 and
14 years compared with background reference populations
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[18, 20]. This indicates that OGDM have an increased risk for
higher BMI or frank obesity when reaching late childhood /
early adolescence.
Little is known how being born LGA influences postnatal
growth although this is a question commonly posed by par-
ents. Only a single longitudinal study investigated LGA neo-
nates as a subgroup and showed that these infants do indeed
have the highest BMI at age 4–7 years [16]. Unfortunately,
there are no data available on height development of OGDM.
Height trajectories give an indication of the extent to which
this variable influences overall BMI.
The current study was performed to answer two questions.
First, to assess whether the growth trajectories of LGA and
non-LGA OGDM are different until early adolescence, with
LGA as a reflection of intrauterine adiposity. Second, to ex-
plore whether growth trajectories of OGDM differ from those
of offspring of mothers with type 1 diabetes (ODM1) or off-
spring of mothers with type 2 diabetes (ODM2). Our data
were compared with several nationwide Dutch growth studies
(mainly the Fifth Dutch Growth Study), which sampled and
assessed children up to adolescence. Since 1955, these studies
have been performed in the Netherlands every 10–15 years




The study group consisted of offspring of women with GDM
who delivered in the University Medical Center, Utrecht, the
Netherlands between 1990 and 2006. All women who deliv-
ered in this period were contacted in 2013. After consent was
obtained, individual offspring growth charts from the Dutch
infant welfare centres were retrieved. The parents were invited
by mail to complete a questionnaire, including questions re-
garding maternal and paternal height, weight, comorbidities
and ethnicity. Parents were asked to provide the most recent
height and weight of the child, measured either by healthcare
workers or themselves.
Infant weight and length were collected through Dutch in-
fant welfare centres, which have a high coverage and record
infant weight, supine length (until 2.0 years) and height (from
2.0 years onward) through standard protocols on specified
dates between birth and age 4 years (1, 4, 6, 9, 11, 14, 18,
24, 36, 45 months). Thereafter, children are measured, by
trained healthcare professionals in the school health service,
at 5.5, 11 and 13 years of age, with a range of 1–2 years
around these ages. Infants’ length and standing height were
measured to the nearest 0.1 cm. Up to age 15 months, children
were weighed naked. Older children were weighed wearing
underwear only, on calibrated mechanical or electronic step
scales. Weight was measured to the nearest 0.1 kg. The med-
ical ethics committee of the University Medical Center
Utrecht, Utrecht in the Netherlands (application no. 13/179;
reference no. WAG/om/13/053639) approved this study (9
April 2013).
GDM was diagnosed in 79% of the women using the 75 g
oral glucose tolerance test, and in the remaining participants
through elevated fasting glucose levels or an abnormal glu-
cose profile showing hyperglycaemia.
Data collection
Baseline maternal characteristics at pregnancy and informa-
tion on pregnancy outcomes were retrieved from records of
the University Medical Center Utrecht. Parents provided in-
formation regarding their own current height and weight, ed-
ucational status and current height and weight for each child
when they completed the written questionnaire. Birthweight
SDS was calculated as follows: (birthweight − mean
birthweight for sex, parity and gestational age) / SD for sex,
parity and gestational age, based on Dutch reference data [23].
LGA was defined as birthweight ≥90th percentile corrected
for gestational age, sex and parity [23]. The conditional target
height of offspring was calculated based on parental height
according to Hermanussen and Cole [24] and adapted to
Dutch growth standards [25]. Length and height of OGDM
were expressed as SDS for age and sex based on the Fifth
Dutch Growth Study performed in 2009 [26]. BMI was cal-
culated from height and weight with the following formula:
weight (kg) / (height [m])2. BMI was expressed as SDS for the
1980 nationwide growth study, in which SDS 0 equals the
age- and sex-specific mean of the 1980 Dutch reference pop-
ulation [27]. These 1980 data are used as the Dutch normative
standard for BMI, thus reflecting a degree of overweight and
obesity in the study group. Our data were also compared with
the 2009 Dutch BMI data to enable comparison with the cur-
rent child population [28]. The values from the 2009 nation-
wide study were plotted in the BMI SDS graphs for visual
comparison of our offspring from the diabetic pregnancies,
to show the effect of the obesity epidemic in a nationwide
cohort. A description of the ODM1 and ODM2 population
has been published previously [29].
Statistical analysis
The longitudinal analyses fitted smooth, flexible curves with a
random-effects model to estimate the growth trajectory of
OGDM, and the subgroups non-LGA OGDM and LGA
OGDM. The mixed model addressed the correlation of repeat-
ed height and BMI SDS measurements obtained within the
same child, as well as time-independent variables (maternal
age at delivery, parity, educational level, employment hours,
marital status, ethnicity, breastfeeding, preconception HbA1c,
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mean pregnancy HbA1c, paternal BMI, paternal ethnicity or
paternal diabetes) and accommodates to the available values
in the dataset. Fixed effects included the covariates maternal
diabetes type (GDM), LGA (yes, no), time (age in years) and
the interaction between time and maternal diabetes type to
show increases or decreases in growth over time. Random
effects were intercept and time. Potential confounders were
the previously mentioned time-independent variables; these
were labelled as covariates in a sensitivity analysis. If the
addition of a covariate to the model changed the estimate by
more than 10%, we considered this a confounder. In a next
step, we checked whether these potential confounders
changed the model by visual inspection of the graphs.
Given the known rapid decreases in BMI SDS during the
first year of life in LGA infants, in both diabetic and non-
diabetic populations [30–33], we separately analysed the
growth trajectories in the first year of life and the years
thereafter.
In a model with the factors as fixed effects and random
effects (mentioned before), the models were examined using
the Akaike’s information criterion and Bayesian information
criterion. The best model fit had the lowest Akaike’s and
Bayesian information criteria, which included a linear and
square interaction of diabetes with age, with intercept and
age as a random effect, to determine the trajectories for BMI
and height SDS. Consequently, for the growth SDS points in
the square model, the values of OGDM, non-LGA OGDM
and LGA OGDM were modelled as follows:
SDS ¼ Interceptþ β0ij þ β1ij ageð Þ þ β2ij ageð Þ2
where β0 represents the intercept, βi is the diabetes type (e.g.
maternal GDM), βj is LGA and age is offspring age in years.
Data were analysed using IBM SPSS Statistics version 23.0 for
Mac (released 2013; Armonk, NY, USA) and Microsoft Excel
for Mac2011 (Impressa Systems, Santa Rosa, CA, USA).
Software prepared by the Dutch Growth Research Foundation
(Growth Analyser 3.5; Rotterdam, the Netherlands; https://
growthanalyser.org/), was used to calculate height SDS using
the 2009 data from the Fifth Dutch Growth Study [26] and
BMI SDS using the 1980 Dutch nationwide data, which are
used as normative standards for present day Dutch children [27].
Results
Population characteristics
From 1990 to 2006, 468 offspring and their 406 mothers were
identified; efforts were made to contact all parents through
mail, telephone and e-mail but 58% of the mothers (n = 235)
were untraceable as they had moved to an unknown address or
their telephone had been disconnected. Another 78 (19%)
women refused further participation, resulting in informed
consent being provided for 104 children (22%) from 93
mothers (23%). From five women, infants from two consecu-
tive pregnancies were included and there were six dichorionic
diamniotic twins. We performed an additional analysis after
randomly selecting only one of each twin pair. Since this
showed comparable results to the analyses using both twins,
we decided to include all twins on which we had data. One
infant with trisomy 21 was excluded; there were no infants
with major congenital malformations in the study population.
Maternal BMI and age were not different between responders
and non-responders. However, ethnicity affected the response:
more Dutch women of European descent were in the respond-
er group and more women of Mediterranean descent were in
the non-responder group.
The baseline characteristics of the 93mothers and 104 infants
included in the study are displayed in Table 1. The mean ± SD
number of measurements of height and weight per child was
7.4 ± 2 between birth and 14 years of age, with a total of 771
measurements. Median maternal (interquartile range) BMI was
25.8 (7.8) kg/m2, with 82% of the women being of European
descent; paternal BMI was 25.5 (3.8) kg/m2, with 87% being of
European descent. Forty-nine per cent of offspring were female
sex. Median birthweight was 3530 (725) g, with 24% being
LGA. Treatment with insulin was given to women during 50
(48%) of the 104 pregnancies; for the remainder, only dietary
advice was given. Five (4.8%) infants were small for gestational
age (birthweight ≤10th percentile).
Growth trajectories: age 1–12 months
During the first year of life, the length of the newborns did not
differ significantly between non-LGA and LGA infants, al-
though LGA OGDM were slightly longer than non-LGA off-
spring (Fig. 1a). BMI SDS decreased in both non-LGA and
LGA OGDM over the first year of life, with the LGA OGDM
having a slightly higher (but not significantly different) BMI
SDS than non-LGA infants (Fig. 1b).
Growth trajectories: age 1–14 years
Height The height SDS for OGDM from age 1 to age 14 years
was similar to that found in the 2009 Dutch Growth Study (SDS
0), with a slight decrease in early adolescence (Fig. 2a).
Although LGA OGDM were slightly taller than non-LGA
OGDM, the difference was not statistically significant (Fig. 2b).
Comparison with the 2009 (Fifth) Dutch Growth Study In
Fig. 2c, d the BMI SDS is depicted from age 1–14 years,
together with that of the 2009 reference population. It was
not possible to make statistical comparisons between data
from the current study and data from the 2009 nationwide
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(Fifth) Dutch Growth Study because of differences in defini-
tions and methodology (as outlined in the Discussion).
However, visual comparison revealed that, until late child-
hood (age 8–10 years), the BMI SDS for the total group was
similar to that for the 2009 (Fifth) Dutch Growth Study,
whereas, after this age, the BMI SDS of the current population
was higher (Fig. 2c).
BMI Subgroup analysis showed different growth trajectories
between LGA and non-LGA OGDM, but the difference did
not reach statistical significance (Fig. 2d, p = 0.07). LGA
OGDM had a higher BMI SDS at 1 year of age and their
BMI SDS continued to increase until late childhood (age 8–
10 years), plateauing thereafter; non-LGA OGDM showed a
steady increase in BMI SDS up to age 14 years, a BMI trajec-
tory resembling that of Dutch boys and girls of the 2009
population.
The sensitivity analyses included examination of each of
the following covariates separately: maternal age at pregnan-
cy; parity; maternal educational level and employment type;
maternal and paternal ethnicity; maternal prepregnancy BMI;
and current paternal BMI. None of these factors had a statis-
tically significant effect on the slope of the models.
Comparable results were also obtained in analyses per-
formed after excluding twins and in nulliparous women only.
Therefore, all of these infants were included in the final anal-
yses. A subgroup analysis for OGDM of European descent
(82%) vs non-European descent was not performed due to
great ethnic heterogeneity in the latter group.
Comparison with ODM1 and ODM2 Figure 3 shows the
growth trajectories of OGDM together with those previously
reported for ODM1 and ODM2. The latter data were obtained
using the same methodology [29]. The LGA and non-LGA
OGDM subgroups both had a lower BMI SDS than the equiv-
alent ODM2 subgroups but a higher BMI than the ODM1
subgroups. Between the ages of 1 and 14 years, non-LGA
OGDM were comparable with non-LGA ODM1 and the
2009 Dutch Growth Study (shown in Fig. 2), suggesting that
the risk for obesity in these subgroups is not increased. LGA
OGDM showed slightly higher BMI SDS than LGA ODM1
after the age of 1 year, but values were lower than in either of





Maternal BMI, kg/m2 25.8 (7.8)a
Maternal age at delivery, years 34 ± 4
Multiparous, n (%) 66 (64)
OGTT performed in pregnancy, n (%) 82 (79)
Mean pregnancy HbA1c, mmol/mol 39 ± 5.5
Mean pregnancy HbA1c, % 5.8 ± 0.5
b
Insulin treatment in pregnancy, n (%) 50 (48)
Pre-eclampsia, n (%) 7 (7)
Caesarean section, n (%) 43 (41)
Gestational age at delivery, weeks 39 (2)
Female sex, n (%) 51 (49)
Birthweight, g 3530 (725)
LGA, n (%) 25 (24)
Birthweight z score 0.57 (1.3)
Neonatal admissions to medium or
intensive care, n (%)
55 (53)
Breastfeeding at 1 week, n (%) 61 (73)c
Conditional target height boys, cm 181.7 ± 4.3
Conditional target height girls, cm 169.7 ± 3.9
Parents
Mothers, n 93
Maternal ethnicity European descent, n (%) 76 (82)
Paternal ethnicity European descent, n (%) 81 (87)
Current paternal BMI, kg/m2 25.5 (3.8)c
Maternal education (university of applied
sciences), n (%)
24 (29)a
Maternal full-time employment, n (%) 14 (17)a
Values are mean ± SD or median (interquartile range), unless stated
otherwise
a 10 missing values because of missing questionnaire data
b 63 missing values because HbA1c was not routinely analysed in
pregnancy
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Fig. 1 Mixed model for (a) length SDS and (b) BMI SDS for non-LGA
(dashed lines) and LGA (solid lines) OGDM at 1–12 months of age
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the ODM2 subgroups. Thus ODM2 (LGA and non-LGA) had
the highest BMI SDS.
Discussion
This study shows that non-LGA and LGA OGDM display
different BMI SDS trajectories during childhood, both groups
reaching slightly higher values than those of the 2009 (Fifth)
Dutch Growth Study. Although LGA OGDM had the higher
scores, both subgroups of OGDMhad amean BMI SDS of less
than +1 SD when they reached early adolescence, indicating
that their risk for becoming overweight in the short term is
likely to be limited. The height SDS for non-LGA and LGA
OGDM was comparable with that of the 2009 background
population. In both the Dutch Growth Study and our OGDM
group, BMI SDS compared with the 1980 nationwide study
was increased, suggesting a gradual shift in offspring BMI
reference values and an increased incidence of overweight/
obesity in both the reference group and the OGDM since the
1980s [28].
It is becoming increasingly clear that a hyperglycaemic
intrauterine environment is responsible for an increased risk
of diseases in childhood and later adulthood. The relatively
overnourished offspring of gestational diabetic pregnancies
are prone to later development of obesity and diabetes. This
is due, not only to genetic susceptibility [34], but also to ex-
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Fig. 2 (a, b) Mixed model for height SDS (a) for all OGDM and (b) for
non-LGA and LGA OGDM at age 1–14 years. (c, d) Mixed model for
BMI SDS (c) for all OGDM at age 1–14 years and (d) for non-LGA and
LGA OGDM at age 1–14 years. Both (c) and (d) also show reference
values from the 2009 reference population for Dutch boys and girls
(reference values adapted from Schonbeck et al [28], based on values
from Cole and Roede [27]). Solid lines, all OGDM; short dashed lines,
non-LGA OGDM; dashed-dotted lines, LGA OGDM; dotted lines, ref-



































Fig. 3 (a) Mixed model for BMI SDS for ODM1, ODM2 and OGDM
aged 1–14 years. Blue line, OGDM; pink line, ODM1; green line,
ODM2. (b) BMI SDS for non-LGA and LGA ODM1, ODM2 and
OGDM aged 1–14 years. Reference values (ODM1 and ODM2) for
BMI SDS for ages 1 to 14 years are adapted from the 2009 nationwide
study for Dutch boys and girls [28], based on values fromCole andRoede
[27]). Blue line, LGA OGDM; blue dotted line, non-LGA OGDM; pink
line, LGA ODM1; pink dotted line, non-LGA ODM1; green line, LGA
ODM2; green dotted line, non-LGA ODM2
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potential for epigenetic changes in the fetal phenotype [35].
These intrauterine phenomena contribute to childhood obesity
and possibly to obesity and diabetes in adulthood and an in-
creased risk for cardiovascular disease [36, 37]. Thus, it is
evident that preventive strategies are needed. This matter is
intuitively most relevant for offspring likely to be most at risk:
those born LGA. Therefore, we analysed the growth trajecto-
ries of non-LGA and LGA OGDM separately.
Several cross-sectional studies on OGDM have found evi-
dence for overweight/obesity in this population [7, 9–13].
However, although the available longitudinal BMI data in
OGDM indicate a higher childhood BMI [17, 19, 20], with
sex and maternal prepregnancy BMI as significant contribut-
ing factors [18, 21], results cannot be compared due to differ-
ences in methodology. In the only other longitudinal study in
which LGA and non-LGA infants were studied separately, at
age 4–7 years LGA OGDMwere found to have a higher BMI
than either non-LGA OGDM or LGA offspring from women
without diabetes [16]. In a cross-sectional prospective cohort
of 6- to 11-year old infants, no difference in BMI was found
between LGA and non-LGA OGDM and the offspring of
mothers without diabetes in pregnancy [38].
We found that maternal BMI did not influence the BMI SDS
trajectory of OGDM. This is in contrast to most studies in
which maternal BMI was taken into account [8, 9, 17, 22, 39,
40] andmight be due to the relatively low incidence of maternal
obesity in our study group (mean BMI, 25.8 kg/m2; 30.9%
overweight [BMI 25–29.9 kg/m2] and 22% obese [BMI
≥30 kg/m2] [9, 22, 40]. This is relevant given the higher BMI
in most GDM studies from a range of countries [9, 20].
Apparently, this profile of women with GDM is common in
our region and may represent a clinically different entity (with a
different outcome for their offspring) when compared with oth-
er studies. Previous studies have shown that in 16–17-year-old
adolescents, the relationship between maternal gestational dia-
betes and offspring BMI was attenuated after correction for
maternal prepregnancy BMI [39] and weight gain in pregnancy
[8]. Furthermore, offspring of mothers with gestational diabetes
and a normal BMI did not show an increase in obesity, in
contrast to offspring of obese mothers with gestational diabetes
[9, 40]. Maternal obesity is, therefore, a strong predictor of
childhood obesity [14] and a higher childhood BMI is related
to maternal BMI [21] in pregnancies complicated by GDM. In
our cohort of mothers with GDM, the relatively low maternal
BMI may explain the limited effect on childhood BMI.
In the literature we did not find any studies comparing the
growth trajectories of OGDM with those of ODM1 and
ODM2 separately. Such a comparison is essential when study-
ing (epi)genetic pathways of obesity. Figure 3 clearly shows
that ODM2 have the highest risk of childhood obesity. The
most striking difference between the GDM, type 1 diabetes
and type 2 diabetes groups was the maternal BMI, which was
higher in women with type 2 diabetes (31 kg/m2), compared
with women with type 1 diabetes (24 kg/m2) and those with
GDM (26 kg/m2). This highlights the importance of maternal
BMI with respect to infant growth.
Only a few studies are available that examine a heterogenic
group consisting of ODM1, ODM2 and OGDM [15, 41–43];
ODM1 and OGDMhave been compared as separate groups in
only two studies. Overweight rates in OGDM and ODM1
were twice those of the background population [44], with a
higher risk for obesity at age 18–20 years in OGDM and only
a weak association for ODM1 [45].
Methodological considerations
This study was performed at a single centre, where pregnant
women with GDM were diagnosed and treated according to
the same protocol.
A longitudinal control group was not available for compar-
ison. We could, however, compare our data with nationwide
data from the Dutch population [26–28]. The reported BMI
and height SDS were calculated based on these population
values and the latter were plotted as graphs for comparison
[28]. Unfortunately, it was not possible to calculate statistical
significance between the OGDM subgroups and the nation-
wide population because the complete set of raw (cross-
sectional) data from the Dutch Growth Study was not avail-
able for analysis.
In this study, we only received informed consent from
23% of all eligible mothers. The response rate was lower than
that reported in the literature (ranging from 46% to 66% [10,
18, 20, 39]; although response rates were not reported in most
studies), illustrating that this cohort is hard to trace and re-
cruit. This issue is present explicitly or implicitly in many
studies. A prospective cohort study would be the best way
to include and follow-up the offspring of pregnant women
with GDM.
In the Netherlands, GDM is most prevalent in the sub-
groups of the population that also have a high incidence of
type 2 diabetes, including natives from Turkey, Morocco,
Suriname and the Caribbean islands. These groups were
under-represented in the current study, possibly because some
of these minority populations are under-represented in our
region or because the parents and offspring in these groups
are sometimes difficult to trace.
Given the ethnic heterogeneity of our study population, a
subgroup analysis was not performed. BMI SDS of OGDM in
our cohortmight have been higher if moreMediterranean-Dutch
children had participated [46]. Although the mean growth tra-
jectories, as depicted in the figures, appeared to be different,
statistical significance was not always reached for non-LGA
OGDM vs LGA OGDM, which may partly be due to the small
numbers of Mediterranean-Dutch children involved.
Tanner stage and onset of puberty were not recorded in the
current study and, thus, the impact of this natural process on
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the current group is unknown. By using SDS values from the
nationwide study, in which children at different stages of pu-
berty were included, the effect of puberty on height and BMI
SDS trajectory is evened out.
In conclusion, this is the first study to analyse longitudinal
growth trajectories in OGDM up to the age of 14 years with
separate height and BMI SDS for LGA and non-LGA off-
spring. Growth trajectories were only slightly above those of
the Dutch reference population (e.g. Dutch Growth Study),
indicating that the risk of OGDM becoming overweight in
adolescence seems limited, at least in a population with a
low incidence of maternal obesity. Compared with offspring
of women with pregestational diabetes, we showed that
ODM2 are at highest risk of becoming overweight in early
adolescence, followed by LGA ODM1. Non-LGA ODM1
had a growth trajectory comparable with that of the reference
population. This study gives a broad view on the intrauterine
origins of adult disease in offspring of women with diabetes.
Parents and healthcare workers should carefully consider the
risk of obesity in offspring of women with diabetes, especially
infants born LGA, and should initiate preventive measures
where possible. These may include diet and lifestyle coaching
for children and parents.
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